Continuity Biosciences LLC

Continuity Biosciences LLC

This company develops implantable nanofluidic and iontophoretic drug delivery platforms to treat patients with cancer, diabetes and infectious diseases.

Intarcia Therapeutics

This biopharmaceutical company develops subcutaneous drug delivery implants for patients with chronic diseases such as type 2 diabetes and HIV.

Chameleon Biosciences

This company develops immune-evading gene therapy delivery platforms for pharmaceutical firms and patients with genetic disorders.

Modulari-T Bioscience

This company develops modular immune receptors and delivery vehicles for cell and gene therapies targeting oncology, autoimmunity and regenerative medicine patients.

G2GBIO

This company develops long-acting injectable medicines and drug delivery platforms for pharmaceutical companies and patients with chronic diseases.

Optimeos Life Sciences

This company develops nanoparticle drug delivery systems and long-acting injectables for pharmaceutical partners to enable targeted intracellular delivery of genetic medicines and proteins.

PNAS Therapeutics

This company develops a one-step drug delivery platform to create regenerative therapies and enhanced pharmaceutical formulations for biotechnology and healthcare partners.

Surf Bio

This company develops drug stabilisation and delivery platforms for pharmaceutical manufacturers to enable high-concentration subcutaneous administration of biologics and vaccines.